CX3CL1 and Alzheimer disease: Furthermore, when peripheral blood mononuclear cells (PBMCs) obtained from human donors were incubated with a blood–brain barrier in vitro model, those cells obtained from Alzheimer’s disease patients stimulated the production of CX3CL1 in both sides of the barrier [21].